vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and Vital Farms, Inc. (VITL). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($263.6M vs $213.6M, roughly 1.2× Vital Farms, Inc.). BALCHEM CORP runs the higher net margin — 14.9% vs 7.6%, a 7.2% gap on every dollar of revenue. On growth, Vital Farms, Inc. posted the faster year-over-year revenue change (28.7% vs 9.8%). Over the past eight quarters, Vital Farms, Inc.'s revenue compounded faster (20.2% CAGR vs 4.9%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Vital Tomosi Dairy Limited is a dairy processing company in Uganda. The company is a joint venture between Vital Capital Fund, "an impact investing fund primarily focused on Sub-Saharan Africa", and "Tomosi Dairy Farms, a Ugandan producer of dairy products".
BCPC vs VITL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $213.6M |
| Net Profit | $39.2M | $16.3M |
| Gross Margin | 35.6% | 35.8% |
| Operating Margin | 19.8% | 10.0% |
| Net Margin | 14.9% | 7.6% |
| Revenue YoY | 9.8% | 28.7% |
| Net Profit YoY | 16.8% | 54.3% |
| EPS (diluted) | $1.21 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | $213.6M | ||
| Q3 25 | $267.6M | $198.9M | ||
| Q2 25 | $255.5M | $184.8M | ||
| Q1 25 | $250.5M | $162.2M | ||
| Q4 24 | $240.0M | $166.0M | ||
| Q3 24 | $239.9M | $145.0M | ||
| Q2 24 | $234.1M | $147.4M | ||
| Q1 24 | $239.7M | $147.9M |
| Q4 25 | $39.2M | $16.3M | ||
| Q3 25 | $40.3M | $16.4M | ||
| Q2 25 | $38.3M | $16.6M | ||
| Q1 25 | $37.1M | $16.9M | ||
| Q4 24 | $33.6M | $10.6M | ||
| Q3 24 | $33.8M | $7.4M | ||
| Q2 24 | $32.1M | $16.3M | ||
| Q1 24 | $29.0M | $19.0M |
| Q4 25 | 35.6% | 35.8% | ||
| Q3 25 | 35.7% | 37.7% | ||
| Q2 25 | 36.4% | 38.9% | ||
| Q1 25 | 35.2% | 38.5% | ||
| Q4 24 | 36.0% | 36.1% | ||
| Q3 24 | 35.6% | 36.9% | ||
| Q2 24 | 35.5% | 39.1% | ||
| Q1 24 | 34.0% | 39.8% |
| Q4 25 | 19.8% | 10.0% | ||
| Q3 25 | 20.4% | 10.8% | ||
| Q2 25 | 20.1% | 12.9% | ||
| Q1 25 | 20.4% | 13.4% | ||
| Q4 24 | 19.8% | 7.8% | ||
| Q3 24 | 20.0% | 6.4% | ||
| Q2 24 | 19.6% | 11.6% | ||
| Q1 24 | 17.4% | 16.3% |
| Q4 25 | 14.9% | 7.6% | ||
| Q3 25 | 15.1% | 8.3% | ||
| Q2 25 | 15.0% | 9.0% | ||
| Q1 25 | 14.8% | 10.4% | ||
| Q4 24 | 14.0% | 6.4% | ||
| Q3 24 | 14.1% | 5.1% | ||
| Q2 24 | 13.7% | 11.1% | ||
| Q1 24 | 12.1% | 12.9% |
| Q4 25 | $1.21 | $0.35 | ||
| Q3 25 | $1.24 | $0.36 | ||
| Q2 25 | $1.17 | $0.36 | ||
| Q1 25 | $1.13 | $0.37 | ||
| Q4 24 | $1.03 | $0.23 | ||
| Q3 24 | $1.03 | $0.16 | ||
| Q2 24 | $0.98 | $0.36 | ||
| Q1 24 | $0.89 | $0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $48.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $351.3M |
| Total Assets | $1.7B | $518.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $48.8M | ||
| Q3 25 | $65.1M | $93.8M | ||
| Q2 25 | $65.4M | $108.2M | ||
| Q1 25 | $49.9M | $156.3M | ||
| Q4 24 | $49.5M | $150.6M | ||
| Q3 24 | $73.7M | $149.5M | ||
| Q2 24 | $63.7M | $133.2M | ||
| Q1 24 | $60.3M | $113.8M |
| Q4 25 | $1.3B | $351.3M | ||
| Q3 25 | $1.3B | $331.2M | ||
| Q2 25 | $1.3B | $309.8M | ||
| Q1 25 | $1.2B | $288.9M | ||
| Q4 24 | $1.1B | $269.3M | ||
| Q3 24 | $1.2B | $253.4M | ||
| Q2 24 | $1.1B | $238.4M | ||
| Q1 24 | $1.1B | $213.3M |
| Q4 25 | $1.7B | $518.7M | ||
| Q3 25 | $1.7B | $481.5M | ||
| Q2 25 | $1.7B | $430.8M | ||
| Q1 25 | $1.6B | $376.9M | ||
| Q4 24 | $1.6B | $359.3M | ||
| Q3 24 | $1.6B | $344.7M | ||
| Q2 24 | $1.6B | $320.5M | ||
| Q1 24 | $1.6B | $300.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $5.8M |
| Free Cash FlowOCF − Capex | — | $-32.1M |
| FCF MarginFCF / Revenue | — | -15.1% |
| Capex IntensityCapex / Revenue | — | 17.8% |
| Cash ConversionOCF / Net Profit | 1.72× | 0.35× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-48.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | $5.8M | ||
| Q3 25 | $65.6M | $23.4M | ||
| Q2 25 | $47.3M | $-761.0K | ||
| Q1 25 | $36.5M | $5.3M | ||
| Q4 24 | $52.3M | $14.8M | ||
| Q3 24 | $51.3M | $10.0M | ||
| Q2 24 | $45.0M | $16.1M | ||
| Q1 24 | $33.4M | $23.9M |
| Q4 25 | — | $-32.1M | ||
| Q3 25 | — | $-10.6M | ||
| Q2 25 | — | $-7.6M | ||
| Q1 25 | — | $2.1M | ||
| Q4 24 | — | $-3.4M | ||
| Q3 24 | — | $6.4M | ||
| Q2 24 | — | $10.5M | ||
| Q1 24 | — | $22.6M |
| Q4 25 | — | -15.1% | ||
| Q3 25 | — | -5.3% | ||
| Q2 25 | — | -4.1% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | -2.0% | ||
| Q3 24 | — | 4.4% | ||
| Q2 24 | — | 7.2% | ||
| Q1 24 | — | 15.3% |
| Q4 25 | — | 17.8% | ||
| Q3 25 | — | 17.1% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 10.9% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 3.8% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | 1.72× | 0.35× | ||
| Q3 25 | 1.63× | 1.43× | ||
| Q2 25 | 1.23× | -0.05× | ||
| Q1 25 | 0.98× | 0.31× | ||
| Q4 24 | 1.56× | 1.40× | ||
| Q3 24 | 1.52× | 1.34× | ||
| Q2 24 | 1.40× | 0.99× | ||
| Q1 24 | 1.15× | 1.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
VITL
| Eggs And Egg Related Products | $205.8M | 96% |
| Butter And Butter Related Products | $7.7M | 4% |
